<unk>  is indicated for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract, who have received prior treatment with three or more kinase inhibitor therapies, including imatinib. GIST is type of stomach, bowel, or esophagus tumor.
Ripretinib
Sotorasib
Duvelisib
Copanlisib
Idelalisib
Vosoritide
Triptorelin
Progabide